+关注
jamesrayan
暂无个人介绍
IP属地:未知
1
关注
1
粉丝
0
主题
0
勋章
主贴
热门
jamesrayan
2021-07-24
to the moon
抱歉,原内容已删除
jamesrayan
2021-07-21
nice
Coca-Cola Shares Gain On Strong Q2 Earnings, Raised FY21 Outlook<blockquote>可口可乐股价因第二季度盈利强劲而上涨,并上调了2021财年前景</blockquote>
jamesrayan
2021-07-21
👍🏻
EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection<blockquote>独家:Celularity首席执行官谈“一刀切”产品Palantir Connection</blockquote>
jamesrayan
2021-06-28
buy buy buy
Cathie Wood Buys Another $9.6M In Uipath, Raises Stake In Automation Company To $670M<blockquote>Cathie Wood又以960万美元收购了Uipath,将自动化公司的股份增至6.7亿美元</blockquote>
jamesrayan
2021-02-18
Cool
抱歉,原内容已删除
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3572672756847501","uuid":"3572672756847501","gmtCreate":1609579702418,"gmtModify":1624862867179,"name":"jamesrayan","pinyin":"jamesrayan","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":1,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.31%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":174802757,"gmtCreate":1627088973479,"gmtModify":1633768134196,"author":{"id":"3572672756847501","authorId":"3572672756847501","name":"jamesrayan","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572672756847501","authorIdStr":"3572672756847501"},"themes":[],"htmlText":"to the moon","listText":"to the moon","text":"to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/174802757","repostId":"2153980423","repostType":4,"isVote":1,"tweetType":1,"viewCount":1881,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176117712,"gmtCreate":1626871356236,"gmtModify":1633770266861,"author":{"id":"3572672756847501","authorId":"3572672756847501","name":"jamesrayan","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572672756847501","authorIdStr":"3572672756847501"},"themes":[],"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/176117712","repostId":"2153645824","repostType":4,"repost":{"id":"2153645824","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626870335,"share":"https://www.laohu8.com/m/news/2153645824?lang=zh_CN&edition=full","pubTime":"2021-07-21 20:25","market":"hk","language":"en","title":"Coca-Cola Shares Gain On Strong Q2 Earnings, Raised FY21 Outlook<blockquote>可口可乐股价因第二季度盈利强劲而上涨,并上调了2021财年前景</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2153645824","media":"Benzinga","summary":"\n","content":"<p><ul> <li><b><a href=\"https://laohu8.com/S/KO\">Coca-Cola</a> Co</b> reported second-quarter FY21 net revenue growth of 41.3% year-on-year to $10.1 billion, beating the analyst consensus of $9.25 billion. <a href=\"https://laohu8.com/S/UNT\">Unit</a> case volume grew 18% in the quarter.</li> <li>Revenue growth was driven by the ongoing recovery in markets as the coronavirus-related uncertainty is starting to decrease.</li> <li>Revenue performance included 26% growth in concentrate sales and 11% growth in price/mix.</li> <li>The operating margin was 29.8%, while the comparable operating margin improved to 31.7%. Operating income for the quarter rose 52% to $3.02 billion.</li> <li>Cash flow generated from operating activities was $5.5 billion.</li> <li>Comparable EPS of $0.68 beat the analyst consensus of $0.55.</li> <li>\"Our results in the second quarter show how our business is rebounding faster than the overall economic recovery, led by our accelerated transformation,\" said CEO James Quincey.</li> <li><b>Outlook</b>: Coca-Cola sees FY21 organic revenue growth of 12% - 14%, versus prior outlook for of high single digits growth.</li> <li>It expects FY21 comparable EPS growth of 13% - 15%, versus previous guidance for percentage growth of high single digits to low double digits versus $1.95 in 2020. The growth expectations exceed analyst FY21 EPS consensus of $2.18.</li> <li><b>Price action:</b> KO shares are trading higher by 2.10% at $57.00 in premarket on the last check Wednesday.</li> </ul> <img src=\"https://static.tigerbbs.com/3d370c35873b63d62ebec60598ee7d15\" tg-width=\"704\" tg-height=\"486\" referrerpolicy=\"no-referrer\"></p><p><blockquote><ul><li><b><a href=\"https://laohu8.com/S/KO\">可口可乐</a>Co</b>报告称,21财年第二季度净收入同比增长41.3%,达到101亿美元,超出分析师预期的92.5亿美元。<a href=\"https://laohu8.com/S/UNT\">单位</a>本季度案件量增长了18%。</li><li>随着冠状病毒相关的不确定性开始减少,市场持续复苏推动了收入增长。</li><li>收入表现包括精矿销售额增长26%,价格/组合增长11%。</li><li>营业利润率为29.8%,可比营业利润率提高至31.7%。该季度营业收入增长52%至30.2亿美元。</li><li>经营活动产生的现金流为55亿美元。</li><li>可比每股收益为0.68美元,超过分析师预期的0.55美元。</li><li>首席执行官詹姆斯·昆西(James Quincey)表示:“我们第二季度的业绩表明,在我们加速转型的带动下,我们的业务反弹速度快于整体经济复苏。”</li><li><b>世界观</b>:可口可乐预计2021财年有机收入增长12%-14%,而之前的预期为高个位数增长。</li><li>预计2021财年可比每股收益增长13%-15%,而之前的指导是高个位数到低两位数的增长百分比,而2020年为1.95美元。增长预期超过分析师2021财年每股收益2.18美元的共识。</li><li><b>价格走势:</b>周三最后一次盘前检查时,KO股价上涨2.10%,至57.00美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Coca-Cola Shares Gain On Strong Q2 Earnings, Raised FY21 Outlook<blockquote>可口可乐股价因第二季度盈利强劲而上涨,并上调了2021财年前景</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCoca-Cola Shares Gain On Strong Q2 Earnings, Raised FY21 Outlook<blockquote>可口可乐股价因第二季度盈利强劲而上涨,并上调了2021财年前景</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-07-21 20:25</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><ul> <li><b><a href=\"https://laohu8.com/S/KO\">Coca-Cola</a> Co</b> reported second-quarter FY21 net revenue growth of 41.3% year-on-year to $10.1 billion, beating the analyst consensus of $9.25 billion. <a href=\"https://laohu8.com/S/UNT\">Unit</a> case volume grew 18% in the quarter.</li> <li>Revenue growth was driven by the ongoing recovery in markets as the coronavirus-related uncertainty is starting to decrease.</li> <li>Revenue performance included 26% growth in concentrate sales and 11% growth in price/mix.</li> <li>The operating margin was 29.8%, while the comparable operating margin improved to 31.7%. Operating income for the quarter rose 52% to $3.02 billion.</li> <li>Cash flow generated from operating activities was $5.5 billion.</li> <li>Comparable EPS of $0.68 beat the analyst consensus of $0.55.</li> <li>\"Our results in the second quarter show how our business is rebounding faster than the overall economic recovery, led by our accelerated transformation,\" said CEO James Quincey.</li> <li><b>Outlook</b>: Coca-Cola sees FY21 organic revenue growth of 12% - 14%, versus prior outlook for of high single digits growth.</li> <li>It expects FY21 comparable EPS growth of 13% - 15%, versus previous guidance for percentage growth of high single digits to low double digits versus $1.95 in 2020. The growth expectations exceed analyst FY21 EPS consensus of $2.18.</li> <li><b>Price action:</b> KO shares are trading higher by 2.10% at $57.00 in premarket on the last check Wednesday.</li> </ul> <img src=\"https://static.tigerbbs.com/3d370c35873b63d62ebec60598ee7d15\" tg-width=\"704\" tg-height=\"486\" referrerpolicy=\"no-referrer\"></p><p><blockquote><ul><li><b><a href=\"https://laohu8.com/S/KO\">可口可乐</a>Co</b>报告称,21财年第二季度净收入同比增长41.3%,达到101亿美元,超出分析师预期的92.5亿美元。<a href=\"https://laohu8.com/S/UNT\">单位</a>本季度案件量增长了18%。</li><li>随着冠状病毒相关的不确定性开始减少,市场持续复苏推动了收入增长。</li><li>收入表现包括精矿销售额增长26%,价格/组合增长11%。</li><li>营业利润率为29.8%,可比营业利润率提高至31.7%。该季度营业收入增长52%至30.2亿美元。</li><li>经营活动产生的现金流为55亿美元。</li><li>可比每股收益为0.68美元,超过分析师预期的0.55美元。</li><li>首席执行官詹姆斯·昆西(James Quincey)表示:“我们第二季度的业绩表明,在我们加速转型的带动下,我们的业务反弹速度快于整体经济复苏。”</li><li><b>世界观</b>:可口可乐预计2021财年有机收入增长12%-14%,而之前的预期为高个位数增长。</li><li>预计2021财年可比每股收益增长13%-15%,而之前的指导是高个位数到低两位数的增长百分比,而2020年为1.95美元。增长预期超过分析师2021财年每股收益2.18美元的共识。</li><li><b>价格走势:</b>周三最后一次盘前检查时,KO股价上涨2.10%,至57.00美元。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QTWO":"Q2 Holdings Inc","KO":"可口可乐"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153645824","content_text":"Coca-Cola Co reported second-quarter FY21 net revenue growth of 41.3% year-on-year to $10.1 billion, beating the analyst consensus of $9.25 billion. Unit case volume grew 18% in the quarter.\nRevenue growth was driven by the ongoing recovery in markets as the coronavirus-related uncertainty is starting to decrease.\nRevenue performance included 26% growth in concentrate sales and 11% growth in price/mix.\nThe operating margin was 29.8%, while the comparable operating margin improved to 31.7%. Operating income for the quarter rose 52% to $3.02 billion.\nCash flow generated from operating activities was $5.5 billion.\nComparable EPS of $0.68 beat the analyst consensus of $0.55.\n\"Our results in the second quarter show how our business is rebounding faster than the overall economic recovery, led by our accelerated transformation,\" said CEO James Quincey.\nOutlook: Coca-Cola sees FY21 organic revenue growth of 12% - 14%, versus prior outlook for of high single digits growth.\nIt expects FY21 comparable EPS growth of 13% - 15%, versus previous guidance for percentage growth of high single digits to low double digits versus $1.95 in 2020. The growth expectations exceed analyst FY21 EPS consensus of $2.18.\nPrice action: KO shares are trading higher by 2.10% at $57.00 in premarket on the last check Wednesday.","news_type":1,"symbols_score_info":{"KO":0.9,"QTWO":0.9}},"isVote":1,"tweetType":1,"viewCount":2387,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176117854,"gmtCreate":1626871321678,"gmtModify":1633770267410,"author":{"id":"3572672756847501","authorId":"3572672756847501","name":"jamesrayan","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572672756847501","authorIdStr":"3572672756847501"},"themes":[],"htmlText":"👍🏻","listText":"👍🏻","text":"👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176117854","repostId":"1121414767","repostType":4,"repost":{"id":"1121414767","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626871035,"share":"https://www.laohu8.com/m/news/1121414767?lang=zh_CN&edition=full","pubTime":"2021-07-21 20:37","market":"us","language":"en","title":"EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection<blockquote>独家:Celularity首席执行官谈“一刀切”产品Palantir Connection</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1121414767","media":"Benzinga","summary":"FormerPepsiCo Inc PEPpresident andApple IncAAPLCEOJohn Sculleyraved about Celularity IncCELUMonday o","content":"<p>Former<b>PepsiCo Inc</b> PEPpresident and<b>Apple Inc</b>AAPLCEO<b>John Sculley</b>raved about <b>Celularity Inc</b>CELUMonday on Benzinga's YouTube show \"Power Hour.\"</p><p><blockquote>前者<b>百事可乐公司</b>PEP总裁和<b>苹果公司</b>AAPLCEO<b>约翰·斯卡利</b>赞不绝口<b>细胞公司</b>Benzinga的YouTube节目“Power Hour”中的CELUMonday。</blockquote></p><p> Celularity founder and CEO<b>Robert Harini</b>appeared on \"Power Hour\" for an exclusive interview Tuesday.</p><p><blockquote>Celularity创始人兼首席执行官<b>罗伯特·哈里尼</b>周二出现在“权力时刻”接受独家采访。</blockquote></p><p> Celularity went public via special purpose acquisition company <a href=\"https://laohu8.com/S/GXGX\">GX Acquisition</a> Corp. on July 16.</p><p><blockquote>Celularity通过特殊目的收购公司上市<a href=\"https://laohu8.com/S/GXGX\">GX收购</a>公司于7月16日。</blockquote></p><p> Celularity focuses on delivering cellular medicines derived from the postpartum human placenta, Harini told Benzinga.</p><p><blockquote>Harini告诉Benzinga,Celularity专注于提供源自产后人类胎盘的细胞药物。</blockquote></p><p> Sculley is a founding director and vice chairman of the board at Cellularity.</p><p><blockquote>斯卡利是Cellularity的创始董事兼董事会副主席。</blockquote></p><p> Harini said he's fortunate to work on the noble pursuit of transforming living cells into medicine with Sculley. Harini went on to talk more about Sculley, an award he received from<b>Pope Francis</b>and more.</p><p><blockquote>哈里尼说,他很幸运能与斯卡利一起致力于将活细胞转化为药物的崇高追求。哈里尼接着更多地谈论了斯卡利,他从<b>教皇弗朗西斯</b>还有更多。</blockquote></p><p> <b>Key Highlights:</b></p><p><blockquote><b>主要亮点:</b></blockquote></p><p> <ul> <li>The human placenta is \"nature's stem cell factory.\" Celularity uses the placenta to produce a product that is \"<a href=\"https://laohu8.com/S/AONE.U\">one</a>-size-fits-all.\"</li> <li>Celularity uses<b>Palantir Technologies Inc</b>PLTR 0.05%to enhance the quality of its products. Palantir sought out the partnership because of its deep interest in biological science and the health care industry.</li> <li>One great future opportunity will be to find ways to mitigate the degenerative changes that occur with aging. Cellular biology is \"here to stay.\"</li> <li>Harini developed his passion after being intrigued by the possibility for stem cells to be used as a tool for restoring function in a damaged brain.</li> <li>He believes Celularity's future products will have the quality and economics to help lead the industry.</li> </ul> <b>CELU Price Action:</b>Celularity shares gained 4.05% Tuesday, closing at $21.85.</p><p><blockquote><ul><li>人类胎盘是“大自然的干细胞工厂”。Celularity利用胎盘生产一种产品<a href=\"https://laohu8.com/S/AONE.U\">一</a>-一刀切。”</li><li>细胞性用途<b>Palantir技术公司</b>PLTR 0.05%以提高其产品质量。Palantir寻求合作伙伴关系是因为它对生物科学和医疗保健行业有着浓厚的兴趣。</li><li>未来的一个很好的机会将是找到减轻随着衰老而发生的退行性变化的方法。细胞生物学将“留在这里”。</li><li>Harini对干细胞被用作恢复受损大脑功能的工具的可能性感兴趣后,产生了他的热情。</li><li>他相信Celularity未来的产品将具有帮助引领行业的质量和经济性。</li></ul><b>CELU价格走势:</b>Celularity股价周二上涨4.05%,收于21.85美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection<blockquote>独家:Celularity首席执行官谈“一刀切”产品Palantir Connection</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection<blockquote>独家:Celularity首席执行官谈“一刀切”产品Palantir Connection</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-07-21 20:37</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>Former<b>PepsiCo Inc</b> PEPpresident and<b>Apple Inc</b>AAPLCEO<b>John Sculley</b>raved about <b>Celularity Inc</b>CELUMonday on Benzinga's YouTube show \"Power Hour.\"</p><p><blockquote>前者<b>百事可乐公司</b>PEP总裁和<b>苹果公司</b>AAPLCEO<b>约翰·斯卡利</b>赞不绝口<b>细胞公司</b>Benzinga的YouTube节目“Power Hour”中的CELUMonday。</blockquote></p><p> Celularity founder and CEO<b>Robert Harini</b>appeared on \"Power Hour\" for an exclusive interview Tuesday.</p><p><blockquote>Celularity创始人兼首席执行官<b>罗伯特·哈里尼</b>周二出现在“权力时刻”接受独家采访。</blockquote></p><p> Celularity went public via special purpose acquisition company <a href=\"https://laohu8.com/S/GXGX\">GX Acquisition</a> Corp. on July 16.</p><p><blockquote>Celularity通过特殊目的收购公司上市<a href=\"https://laohu8.com/S/GXGX\">GX收购</a>公司于7月16日。</blockquote></p><p> Celularity focuses on delivering cellular medicines derived from the postpartum human placenta, Harini told Benzinga.</p><p><blockquote>Harini告诉Benzinga,Celularity专注于提供源自产后人类胎盘的细胞药物。</blockquote></p><p> Sculley is a founding director and vice chairman of the board at Cellularity.</p><p><blockquote>斯卡利是Cellularity的创始董事兼董事会副主席。</blockquote></p><p> Harini said he's fortunate to work on the noble pursuit of transforming living cells into medicine with Sculley. Harini went on to talk more about Sculley, an award he received from<b>Pope Francis</b>and more.</p><p><blockquote>哈里尼说,他很幸运能与斯卡利一起致力于将活细胞转化为药物的崇高追求。哈里尼接着更多地谈论了斯卡利,他从<b>教皇弗朗西斯</b>还有更多。</blockquote></p><p> <b>Key Highlights:</b></p><p><blockquote><b>主要亮点:</b></blockquote></p><p> <ul> <li>The human placenta is \"nature's stem cell factory.\" Celularity uses the placenta to produce a product that is \"<a href=\"https://laohu8.com/S/AONE.U\">one</a>-size-fits-all.\"</li> <li>Celularity uses<b>Palantir Technologies Inc</b>PLTR 0.05%to enhance the quality of its products. Palantir sought out the partnership because of its deep interest in biological science and the health care industry.</li> <li>One great future opportunity will be to find ways to mitigate the degenerative changes that occur with aging. Cellular biology is \"here to stay.\"</li> <li>Harini developed his passion after being intrigued by the possibility for stem cells to be used as a tool for restoring function in a damaged brain.</li> <li>He believes Celularity's future products will have the quality and economics to help lead the industry.</li> </ul> <b>CELU Price Action:</b>Celularity shares gained 4.05% Tuesday, closing at $21.85.</p><p><blockquote><ul><li>人类胎盘是“大自然的干细胞工厂”。Celularity利用胎盘生产一种产品<a href=\"https://laohu8.com/S/AONE.U\">一</a>-一刀切。”</li><li>细胞性用途<b>Palantir技术公司</b>PLTR 0.05%以提高其产品质量。Palantir寻求合作伙伴关系是因为它对生物科学和医疗保健行业有着浓厚的兴趣。</li><li>未来的一个很好的机会将是找到减轻随着衰老而发生的退行性变化的方法。细胞生物学将“留在这里”。</li><li>Harini对干细胞被用作恢复受损大脑功能的工具的可能性感兴趣后,产生了他的热情。</li><li>他相信Celularity未来的产品将具有帮助引领行业的质量和经济性。</li></ul><b>CELU价格走势:</b>Celularity股价周二上涨4.05%,收于21.85美元。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CELU":"Celularity Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121414767","content_text":"FormerPepsiCo Inc PEPpresident andApple IncAAPLCEOJohn Sculleyraved about Celularity IncCELUMonday on Benzinga's YouTube show \"Power Hour.\"\nCelularity founder and CEORobert Hariniappeared on \"Power Hour\" for an exclusive interview Tuesday.\nCelularity went public via special purpose acquisition company GX Acquisition Corp. on July 16.\nCelularity focuses on delivering cellular medicines derived from the postpartum human placenta, Harini told Benzinga.\nSculley is a founding director and vice chairman of the board at Cellularity.\nHarini said he's fortunate to work on the noble pursuit of transforming living cells into medicine with Sculley. Harini went on to talk more about Sculley, an award he received fromPope Francisand more.\nKey Highlights:\n\nThe human placenta is \"nature's stem cell factory.\" Celularity uses the placenta to produce a product that is \"one-size-fits-all.\"\nCelularity usesPalantir Technologies IncPLTR 0.05%to enhance the quality of its products. Palantir sought out the partnership because of its deep interest in biological science and the health care industry.\nOne great future opportunity will be to find ways to mitigate the degenerative changes that occur with aging. Cellular biology is \"here to stay.\"\nHarini developed his passion after being intrigued by the possibility for stem cells to be used as a tool for restoring function in a damaged brain.\nHe believes Celularity's future products will have the quality and economics to help lead the industry.\n\nCELU Price Action:Celularity shares gained 4.05% Tuesday, closing at $21.85.","news_type":1,"symbols_score_info":{"CELU":0.9}},"isVote":1,"tweetType":1,"viewCount":1333,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127431428,"gmtCreate":1624861829964,"gmtModify":1633947812972,"author":{"id":"3572672756847501","authorId":"3572672756847501","name":"jamesrayan","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572672756847501","authorIdStr":"3572672756847501"},"themes":[],"htmlText":"buy buy buy","listText":"buy buy buy","text":"buy buy buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/127431428","repostId":"1110515408","repostType":4,"repost":{"id":"1110515408","kind":"news","pubTimestamp":1624859565,"share":"https://www.laohu8.com/m/news/1110515408?lang=zh_CN&edition=full","pubTime":"2021-06-28 13:52","market":"us","language":"en","title":"Cathie Wood Buys Another $9.6M In Uipath, Raises Stake In Automation Company To $670M<blockquote>Cathie Wood又以960万美元收购了Uipath,将自动化公司的股份增至6.7亿美元</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1110515408","media":"Benzinga","summary":"Cathie Wood-led Ark Investment Management on Friday snapped up 136,859 shares, estimated to be worth","content":"<p><div> Cathie Wood-led Ark Investment Management on Friday snapped up 136,859 shares, estimated to be worth about $9.55 million, in UiPath Inc(NYSE:PATH). Shares of the New York-based software automation ...</p><p><blockquote><div>Cathie Wood领导的Ark Investment Management周五抢购了UiPath Inc(纽约证券交易所股票代码:PATH)的136,859股股票,估计价值约955万美元。总部位于纽约的软件自动化公司的股票...</div></blockquote></p><p> <a href=\"https://www.benzinga.com/trading-ideas/long-ideas/21/06/21737470/cathie-wood-buys-another-9-6m-in-uipath-raises-stake-in-automation-company-to-670m\">网页链接</a> </div> </p><p><blockquote><a href=\"https://www.benzinga.com/trading-ideas/long-ideas/21/06/21737470/cathie-wood-buys-another-9-6m-in-uipath-raises-stake-in-automation-company-to-670m\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Buys Another $9.6M In Uipath, Raises Stake In Automation Company To $670M<blockquote>Cathie Wood又以960万美元收购了Uipath,将自动化公司的股份增至6.7亿美元</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Buys Another $9.6M In Uipath, Raises Stake In Automation Company To $670M<blockquote>Cathie Wood又以960万美元收购了Uipath,将自动化公司的股份增至6.7亿美元</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-06-28 13:52</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Cathie Wood-led Ark Investment Management on Friday snapped up 136,859 shares, estimated to be worth about $9.55 million, in UiPath Inc(NYSE:PATH). Shares of the New York-based software automation ...</p><p><blockquote><div>Cathie Wood领导的Ark Investment Management周五抢购了UiPath Inc(纽约证券交易所股票代码:PATH)的136,859股股票,估计价值约955万美元。总部位于纽约的软件自动化公司的股票...</div></blockquote></p><p> <a href=\"https://www.benzinga.com/trading-ideas/long-ideas/21/06/21737470/cathie-wood-buys-another-9-6m-in-uipath-raises-stake-in-automation-company-to-670m\">网页链接</a> </div> </p><p><blockquote><a href=\"https://www.benzinga.com/trading-ideas/long-ideas/21/06/21737470/cathie-wood-buys-another-9-6m-in-uipath-raises-stake-in-automation-company-to-670m\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.benzinga.com/trading-ideas/long-ideas/21/06/21737470/cathie-wood-buys-another-9-6m-in-uipath-raises-stake-in-automation-company-to-670m\">Benzinga</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QSI":"Quantum-Si Inc.","PATH":"UiPath"},"source_url":"https://www.benzinga.com/trading-ideas/long-ideas/21/06/21737470/cathie-wood-buys-another-9-6m-in-uipath-raises-stake-in-automation-company-to-670m","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110515408","content_text":"Cathie Wood-led Ark Investment Management on Friday snapped up 136,859 shares, estimated to be worth about $9.55 million, in UiPath Inc(NYSE:PATH).\nShares of the New York-based software automation company closed 1.04% higher at $69.77 on Friday.\nThe investment firm made the purchase via the ArkGenomic Revolution ETF(BATS:ARKG).\nArk owns PATH shares via all of its six active ETFs. On a consolidated basis, the Wood-led firm now holds over 10 million shares, worth around $670 million in UiPath.\nThe products of the Bucharest, Romania-based software companyare used by organizations to help efficiently automate their various business processes. PATH closed 5.34% higher on Wednesday, giving the company a market valuation of $35.8 billion.\nSome of the other key Ark Invest sells on Friday include Pluristem Therapeutics(NASDAQ:PSTI) and buys include Quantum-Si Inc(NASDAQ:QSI).","news_type":1,"symbols_score_info":{"PSTI":0.9,"QSI":0.9,"PATH":0.9}},"isVote":1,"tweetType":1,"viewCount":1165,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":384974986,"gmtCreate":1613611005045,"gmtModify":1634552959894,"author":{"id":"3572672756847501","authorId":"3572672756847501","name":"jamesrayan","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572672756847501","authorIdStr":"3572672756847501"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/384974986","repostId":"1109567373","repostType":4,"isVote":1,"tweetType":1,"viewCount":1296,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":174802757,"gmtCreate":1627088973479,"gmtModify":1633768134196,"author":{"id":"3572672756847501","authorId":"3572672756847501","name":"jamesrayan","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572672756847501","authorIdStr":"3572672756847501"},"themes":[],"htmlText":"to the moon","listText":"to the moon","text":"to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/174802757","repostId":"2153980423","repostType":4,"isVote":1,"tweetType":1,"viewCount":1881,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176117712,"gmtCreate":1626871356236,"gmtModify":1633770266861,"author":{"id":"3572672756847501","authorId":"3572672756847501","name":"jamesrayan","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572672756847501","authorIdStr":"3572672756847501"},"themes":[],"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/176117712","repostId":"2153645824","repostType":4,"repost":{"id":"2153645824","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626870335,"share":"https://www.laohu8.com/m/news/2153645824?lang=zh_CN&edition=full","pubTime":"2021-07-21 20:25","market":"hk","language":"en","title":"Coca-Cola Shares Gain On Strong Q2 Earnings, Raised FY21 Outlook<blockquote>可口可乐股价因第二季度盈利强劲而上涨,并上调了2021财年前景</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2153645824","media":"Benzinga","summary":"\n","content":"<p><ul> <li><b><a href=\"https://laohu8.com/S/KO\">Coca-Cola</a> Co</b> reported second-quarter FY21 net revenue growth of 41.3% year-on-year to $10.1 billion, beating the analyst consensus of $9.25 billion. <a href=\"https://laohu8.com/S/UNT\">Unit</a> case volume grew 18% in the quarter.</li> <li>Revenue growth was driven by the ongoing recovery in markets as the coronavirus-related uncertainty is starting to decrease.</li> <li>Revenue performance included 26% growth in concentrate sales and 11% growth in price/mix.</li> <li>The operating margin was 29.8%, while the comparable operating margin improved to 31.7%. Operating income for the quarter rose 52% to $3.02 billion.</li> <li>Cash flow generated from operating activities was $5.5 billion.</li> <li>Comparable EPS of $0.68 beat the analyst consensus of $0.55.</li> <li>\"Our results in the second quarter show how our business is rebounding faster than the overall economic recovery, led by our accelerated transformation,\" said CEO James Quincey.</li> <li><b>Outlook</b>: Coca-Cola sees FY21 organic revenue growth of 12% - 14%, versus prior outlook for of high single digits growth.</li> <li>It expects FY21 comparable EPS growth of 13% - 15%, versus previous guidance for percentage growth of high single digits to low double digits versus $1.95 in 2020. The growth expectations exceed analyst FY21 EPS consensus of $2.18.</li> <li><b>Price action:</b> KO shares are trading higher by 2.10% at $57.00 in premarket on the last check Wednesday.</li> </ul> <img src=\"https://static.tigerbbs.com/3d370c35873b63d62ebec60598ee7d15\" tg-width=\"704\" tg-height=\"486\" referrerpolicy=\"no-referrer\"></p><p><blockquote><ul><li><b><a href=\"https://laohu8.com/S/KO\">可口可乐</a>Co</b>报告称,21财年第二季度净收入同比增长41.3%,达到101亿美元,超出分析师预期的92.5亿美元。<a href=\"https://laohu8.com/S/UNT\">单位</a>本季度案件量增长了18%。</li><li>随着冠状病毒相关的不确定性开始减少,市场持续复苏推动了收入增长。</li><li>收入表现包括精矿销售额增长26%,价格/组合增长11%。</li><li>营业利润率为29.8%,可比营业利润率提高至31.7%。该季度营业收入增长52%至30.2亿美元。</li><li>经营活动产生的现金流为55亿美元。</li><li>可比每股收益为0.68美元,超过分析师预期的0.55美元。</li><li>首席执行官詹姆斯·昆西(James Quincey)表示:“我们第二季度的业绩表明,在我们加速转型的带动下,我们的业务反弹速度快于整体经济复苏。”</li><li><b>世界观</b>:可口可乐预计2021财年有机收入增长12%-14%,而之前的预期为高个位数增长。</li><li>预计2021财年可比每股收益增长13%-15%,而之前的指导是高个位数到低两位数的增长百分比,而2020年为1.95美元。增长预期超过分析师2021财年每股收益2.18美元的共识。</li><li><b>价格走势:</b>周三最后一次盘前检查时,KO股价上涨2.10%,至57.00美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Coca-Cola Shares Gain On Strong Q2 Earnings, Raised FY21 Outlook<blockquote>可口可乐股价因第二季度盈利强劲而上涨,并上调了2021财年前景</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCoca-Cola Shares Gain On Strong Q2 Earnings, Raised FY21 Outlook<blockquote>可口可乐股价因第二季度盈利强劲而上涨,并上调了2021财年前景</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-07-21 20:25</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><ul> <li><b><a href=\"https://laohu8.com/S/KO\">Coca-Cola</a> Co</b> reported second-quarter FY21 net revenue growth of 41.3% year-on-year to $10.1 billion, beating the analyst consensus of $9.25 billion. <a href=\"https://laohu8.com/S/UNT\">Unit</a> case volume grew 18% in the quarter.</li> <li>Revenue growth was driven by the ongoing recovery in markets as the coronavirus-related uncertainty is starting to decrease.</li> <li>Revenue performance included 26% growth in concentrate sales and 11% growth in price/mix.</li> <li>The operating margin was 29.8%, while the comparable operating margin improved to 31.7%. Operating income for the quarter rose 52% to $3.02 billion.</li> <li>Cash flow generated from operating activities was $5.5 billion.</li> <li>Comparable EPS of $0.68 beat the analyst consensus of $0.55.</li> <li>\"Our results in the second quarter show how our business is rebounding faster than the overall economic recovery, led by our accelerated transformation,\" said CEO James Quincey.</li> <li><b>Outlook</b>: Coca-Cola sees FY21 organic revenue growth of 12% - 14%, versus prior outlook for of high single digits growth.</li> <li>It expects FY21 comparable EPS growth of 13% - 15%, versus previous guidance for percentage growth of high single digits to low double digits versus $1.95 in 2020. The growth expectations exceed analyst FY21 EPS consensus of $2.18.</li> <li><b>Price action:</b> KO shares are trading higher by 2.10% at $57.00 in premarket on the last check Wednesday.</li> </ul> <img src=\"https://static.tigerbbs.com/3d370c35873b63d62ebec60598ee7d15\" tg-width=\"704\" tg-height=\"486\" referrerpolicy=\"no-referrer\"></p><p><blockquote><ul><li><b><a href=\"https://laohu8.com/S/KO\">可口可乐</a>Co</b>报告称,21财年第二季度净收入同比增长41.3%,达到101亿美元,超出分析师预期的92.5亿美元。<a href=\"https://laohu8.com/S/UNT\">单位</a>本季度案件量增长了18%。</li><li>随着冠状病毒相关的不确定性开始减少,市场持续复苏推动了收入增长。</li><li>收入表现包括精矿销售额增长26%,价格/组合增长11%。</li><li>营业利润率为29.8%,可比营业利润率提高至31.7%。该季度营业收入增长52%至30.2亿美元。</li><li>经营活动产生的现金流为55亿美元。</li><li>可比每股收益为0.68美元,超过分析师预期的0.55美元。</li><li>首席执行官詹姆斯·昆西(James Quincey)表示:“我们第二季度的业绩表明,在我们加速转型的带动下,我们的业务反弹速度快于整体经济复苏。”</li><li><b>世界观</b>:可口可乐预计2021财年有机收入增长12%-14%,而之前的预期为高个位数增长。</li><li>预计2021财年可比每股收益增长13%-15%,而之前的指导是高个位数到低两位数的增长百分比,而2020年为1.95美元。增长预期超过分析师2021财年每股收益2.18美元的共识。</li><li><b>价格走势:</b>周三最后一次盘前检查时,KO股价上涨2.10%,至57.00美元。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QTWO":"Q2 Holdings Inc","KO":"可口可乐"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153645824","content_text":"Coca-Cola Co reported second-quarter FY21 net revenue growth of 41.3% year-on-year to $10.1 billion, beating the analyst consensus of $9.25 billion. Unit case volume grew 18% in the quarter.\nRevenue growth was driven by the ongoing recovery in markets as the coronavirus-related uncertainty is starting to decrease.\nRevenue performance included 26% growth in concentrate sales and 11% growth in price/mix.\nThe operating margin was 29.8%, while the comparable operating margin improved to 31.7%. Operating income for the quarter rose 52% to $3.02 billion.\nCash flow generated from operating activities was $5.5 billion.\nComparable EPS of $0.68 beat the analyst consensus of $0.55.\n\"Our results in the second quarter show how our business is rebounding faster than the overall economic recovery, led by our accelerated transformation,\" said CEO James Quincey.\nOutlook: Coca-Cola sees FY21 organic revenue growth of 12% - 14%, versus prior outlook for of high single digits growth.\nIt expects FY21 comparable EPS growth of 13% - 15%, versus previous guidance for percentage growth of high single digits to low double digits versus $1.95 in 2020. The growth expectations exceed analyst FY21 EPS consensus of $2.18.\nPrice action: KO shares are trading higher by 2.10% at $57.00 in premarket on the last check Wednesday.","news_type":1,"symbols_score_info":{"KO":0.9,"QTWO":0.9}},"isVote":1,"tweetType":1,"viewCount":2387,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176117854,"gmtCreate":1626871321678,"gmtModify":1633770267410,"author":{"id":"3572672756847501","authorId":"3572672756847501","name":"jamesrayan","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572672756847501","authorIdStr":"3572672756847501"},"themes":[],"htmlText":"👍🏻","listText":"👍🏻","text":"👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176117854","repostId":"1121414767","repostType":4,"repost":{"id":"1121414767","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626871035,"share":"https://www.laohu8.com/m/news/1121414767?lang=zh_CN&edition=full","pubTime":"2021-07-21 20:37","market":"us","language":"en","title":"EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection<blockquote>独家:Celularity首席执行官谈“一刀切”产品Palantir Connection</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1121414767","media":"Benzinga","summary":"FormerPepsiCo Inc PEPpresident andApple IncAAPLCEOJohn Sculleyraved about Celularity IncCELUMonday o","content":"<p>Former<b>PepsiCo Inc</b> PEPpresident and<b>Apple Inc</b>AAPLCEO<b>John Sculley</b>raved about <b>Celularity Inc</b>CELUMonday on Benzinga's YouTube show \"Power Hour.\"</p><p><blockquote>前者<b>百事可乐公司</b>PEP总裁和<b>苹果公司</b>AAPLCEO<b>约翰·斯卡利</b>赞不绝口<b>细胞公司</b>Benzinga的YouTube节目“Power Hour”中的CELUMonday。</blockquote></p><p> Celularity founder and CEO<b>Robert Harini</b>appeared on \"Power Hour\" for an exclusive interview Tuesday.</p><p><blockquote>Celularity创始人兼首席执行官<b>罗伯特·哈里尼</b>周二出现在“权力时刻”接受独家采访。</blockquote></p><p> Celularity went public via special purpose acquisition company <a href=\"https://laohu8.com/S/GXGX\">GX Acquisition</a> Corp. on July 16.</p><p><blockquote>Celularity通过特殊目的收购公司上市<a href=\"https://laohu8.com/S/GXGX\">GX收购</a>公司于7月16日。</blockquote></p><p> Celularity focuses on delivering cellular medicines derived from the postpartum human placenta, Harini told Benzinga.</p><p><blockquote>Harini告诉Benzinga,Celularity专注于提供源自产后人类胎盘的细胞药物。</blockquote></p><p> Sculley is a founding director and vice chairman of the board at Cellularity.</p><p><blockquote>斯卡利是Cellularity的创始董事兼董事会副主席。</blockquote></p><p> Harini said he's fortunate to work on the noble pursuit of transforming living cells into medicine with Sculley. Harini went on to talk more about Sculley, an award he received from<b>Pope Francis</b>and more.</p><p><blockquote>哈里尼说,他很幸运能与斯卡利一起致力于将活细胞转化为药物的崇高追求。哈里尼接着更多地谈论了斯卡利,他从<b>教皇弗朗西斯</b>还有更多。</blockquote></p><p> <b>Key Highlights:</b></p><p><blockquote><b>主要亮点:</b></blockquote></p><p> <ul> <li>The human placenta is \"nature's stem cell factory.\" Celularity uses the placenta to produce a product that is \"<a href=\"https://laohu8.com/S/AONE.U\">one</a>-size-fits-all.\"</li> <li>Celularity uses<b>Palantir Technologies Inc</b>PLTR 0.05%to enhance the quality of its products. Palantir sought out the partnership because of its deep interest in biological science and the health care industry.</li> <li>One great future opportunity will be to find ways to mitigate the degenerative changes that occur with aging. Cellular biology is \"here to stay.\"</li> <li>Harini developed his passion after being intrigued by the possibility for stem cells to be used as a tool for restoring function in a damaged brain.</li> <li>He believes Celularity's future products will have the quality and economics to help lead the industry.</li> </ul> <b>CELU Price Action:</b>Celularity shares gained 4.05% Tuesday, closing at $21.85.</p><p><blockquote><ul><li>人类胎盘是“大自然的干细胞工厂”。Celularity利用胎盘生产一种产品<a href=\"https://laohu8.com/S/AONE.U\">一</a>-一刀切。”</li><li>细胞性用途<b>Palantir技术公司</b>PLTR 0.05%以提高其产品质量。Palantir寻求合作伙伴关系是因为它对生物科学和医疗保健行业有着浓厚的兴趣。</li><li>未来的一个很好的机会将是找到减轻随着衰老而发生的退行性变化的方法。细胞生物学将“留在这里”。</li><li>Harini对干细胞被用作恢复受损大脑功能的工具的可能性感兴趣后,产生了他的热情。</li><li>他相信Celularity未来的产品将具有帮助引领行业的质量和经济性。</li></ul><b>CELU价格走势:</b>Celularity股价周二上涨4.05%,收于21.85美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection<blockquote>独家:Celularity首席执行官谈“一刀切”产品Palantir Connection</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection<blockquote>独家:Celularity首席执行官谈“一刀切”产品Palantir Connection</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-07-21 20:37</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>Former<b>PepsiCo Inc</b> PEPpresident and<b>Apple Inc</b>AAPLCEO<b>John Sculley</b>raved about <b>Celularity Inc</b>CELUMonday on Benzinga's YouTube show \"Power Hour.\"</p><p><blockquote>前者<b>百事可乐公司</b>PEP总裁和<b>苹果公司</b>AAPLCEO<b>约翰·斯卡利</b>赞不绝口<b>细胞公司</b>Benzinga的YouTube节目“Power Hour”中的CELUMonday。</blockquote></p><p> Celularity founder and CEO<b>Robert Harini</b>appeared on \"Power Hour\" for an exclusive interview Tuesday.</p><p><blockquote>Celularity创始人兼首席执行官<b>罗伯特·哈里尼</b>周二出现在“权力时刻”接受独家采访。</blockquote></p><p> Celularity went public via special purpose acquisition company <a href=\"https://laohu8.com/S/GXGX\">GX Acquisition</a> Corp. on July 16.</p><p><blockquote>Celularity通过特殊目的收购公司上市<a href=\"https://laohu8.com/S/GXGX\">GX收购</a>公司于7月16日。</blockquote></p><p> Celularity focuses on delivering cellular medicines derived from the postpartum human placenta, Harini told Benzinga.</p><p><blockquote>Harini告诉Benzinga,Celularity专注于提供源自产后人类胎盘的细胞药物。</blockquote></p><p> Sculley is a founding director and vice chairman of the board at Cellularity.</p><p><blockquote>斯卡利是Cellularity的创始董事兼董事会副主席。</blockquote></p><p> Harini said he's fortunate to work on the noble pursuit of transforming living cells into medicine with Sculley. Harini went on to talk more about Sculley, an award he received from<b>Pope Francis</b>and more.</p><p><blockquote>哈里尼说,他很幸运能与斯卡利一起致力于将活细胞转化为药物的崇高追求。哈里尼接着更多地谈论了斯卡利,他从<b>教皇弗朗西斯</b>还有更多。</blockquote></p><p> <b>Key Highlights:</b></p><p><blockquote><b>主要亮点:</b></blockquote></p><p> <ul> <li>The human placenta is \"nature's stem cell factory.\" Celularity uses the placenta to produce a product that is \"<a href=\"https://laohu8.com/S/AONE.U\">one</a>-size-fits-all.\"</li> <li>Celularity uses<b>Palantir Technologies Inc</b>PLTR 0.05%to enhance the quality of its products. Palantir sought out the partnership because of its deep interest in biological science and the health care industry.</li> <li>One great future opportunity will be to find ways to mitigate the degenerative changes that occur with aging. Cellular biology is \"here to stay.\"</li> <li>Harini developed his passion after being intrigued by the possibility for stem cells to be used as a tool for restoring function in a damaged brain.</li> <li>He believes Celularity's future products will have the quality and economics to help lead the industry.</li> </ul> <b>CELU Price Action:</b>Celularity shares gained 4.05% Tuesday, closing at $21.85.</p><p><blockquote><ul><li>人类胎盘是“大自然的干细胞工厂”。Celularity利用胎盘生产一种产品<a href=\"https://laohu8.com/S/AONE.U\">一</a>-一刀切。”</li><li>细胞性用途<b>Palantir技术公司</b>PLTR 0.05%以提高其产品质量。Palantir寻求合作伙伴关系是因为它对生物科学和医疗保健行业有着浓厚的兴趣。</li><li>未来的一个很好的机会将是找到减轻随着衰老而发生的退行性变化的方法。细胞生物学将“留在这里”。</li><li>Harini对干细胞被用作恢复受损大脑功能的工具的可能性感兴趣后,产生了他的热情。</li><li>他相信Celularity未来的产品将具有帮助引领行业的质量和经济性。</li></ul><b>CELU价格走势:</b>Celularity股价周二上涨4.05%,收于21.85美元。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CELU":"Celularity Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121414767","content_text":"FormerPepsiCo Inc PEPpresident andApple IncAAPLCEOJohn Sculleyraved about Celularity IncCELUMonday on Benzinga's YouTube show \"Power Hour.\"\nCelularity founder and CEORobert Hariniappeared on \"Power Hour\" for an exclusive interview Tuesday.\nCelularity went public via special purpose acquisition company GX Acquisition Corp. on July 16.\nCelularity focuses on delivering cellular medicines derived from the postpartum human placenta, Harini told Benzinga.\nSculley is a founding director and vice chairman of the board at Cellularity.\nHarini said he's fortunate to work on the noble pursuit of transforming living cells into medicine with Sculley. Harini went on to talk more about Sculley, an award he received fromPope Francisand more.\nKey Highlights:\n\nThe human placenta is \"nature's stem cell factory.\" Celularity uses the placenta to produce a product that is \"one-size-fits-all.\"\nCelularity usesPalantir Technologies IncPLTR 0.05%to enhance the quality of its products. Palantir sought out the partnership because of its deep interest in biological science and the health care industry.\nOne great future opportunity will be to find ways to mitigate the degenerative changes that occur with aging. Cellular biology is \"here to stay.\"\nHarini developed his passion after being intrigued by the possibility for stem cells to be used as a tool for restoring function in a damaged brain.\nHe believes Celularity's future products will have the quality and economics to help lead the industry.\n\nCELU Price Action:Celularity shares gained 4.05% Tuesday, closing at $21.85.","news_type":1,"symbols_score_info":{"CELU":0.9}},"isVote":1,"tweetType":1,"viewCount":1333,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127431428,"gmtCreate":1624861829964,"gmtModify":1633947812972,"author":{"id":"3572672756847501","authorId":"3572672756847501","name":"jamesrayan","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572672756847501","authorIdStr":"3572672756847501"},"themes":[],"htmlText":"buy buy buy","listText":"buy buy buy","text":"buy buy buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/127431428","repostId":"1110515408","repostType":4,"repost":{"id":"1110515408","kind":"news","pubTimestamp":1624859565,"share":"https://www.laohu8.com/m/news/1110515408?lang=zh_CN&edition=full","pubTime":"2021-06-28 13:52","market":"us","language":"en","title":"Cathie Wood Buys Another $9.6M In Uipath, Raises Stake In Automation Company To $670M<blockquote>Cathie Wood又以960万美元收购了Uipath,将自动化公司的股份增至6.7亿美元</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1110515408","media":"Benzinga","summary":"Cathie Wood-led Ark Investment Management on Friday snapped up 136,859 shares, estimated to be worth","content":"<p><div> Cathie Wood-led Ark Investment Management on Friday snapped up 136,859 shares, estimated to be worth about $9.55 million, in UiPath Inc(NYSE:PATH). Shares of the New York-based software automation ...</p><p><blockquote><div>Cathie Wood领导的Ark Investment Management周五抢购了UiPath Inc(纽约证券交易所股票代码:PATH)的136,859股股票,估计价值约955万美元。总部位于纽约的软件自动化公司的股票...</div></blockquote></p><p> <a href=\"https://www.benzinga.com/trading-ideas/long-ideas/21/06/21737470/cathie-wood-buys-another-9-6m-in-uipath-raises-stake-in-automation-company-to-670m\">网页链接</a> </div> </p><p><blockquote><a href=\"https://www.benzinga.com/trading-ideas/long-ideas/21/06/21737470/cathie-wood-buys-another-9-6m-in-uipath-raises-stake-in-automation-company-to-670m\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Buys Another $9.6M In Uipath, Raises Stake In Automation Company To $670M<blockquote>Cathie Wood又以960万美元收购了Uipath,将自动化公司的股份增至6.7亿美元</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Buys Another $9.6M In Uipath, Raises Stake In Automation Company To $670M<blockquote>Cathie Wood又以960万美元收购了Uipath,将自动化公司的股份增至6.7亿美元</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-06-28 13:52</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Cathie Wood-led Ark Investment Management on Friday snapped up 136,859 shares, estimated to be worth about $9.55 million, in UiPath Inc(NYSE:PATH). Shares of the New York-based software automation ...</p><p><blockquote><div>Cathie Wood领导的Ark Investment Management周五抢购了UiPath Inc(纽约证券交易所股票代码:PATH)的136,859股股票,估计价值约955万美元。总部位于纽约的软件自动化公司的股票...</div></blockquote></p><p> <a href=\"https://www.benzinga.com/trading-ideas/long-ideas/21/06/21737470/cathie-wood-buys-another-9-6m-in-uipath-raises-stake-in-automation-company-to-670m\">网页链接</a> </div> </p><p><blockquote><a href=\"https://www.benzinga.com/trading-ideas/long-ideas/21/06/21737470/cathie-wood-buys-another-9-6m-in-uipath-raises-stake-in-automation-company-to-670m\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.benzinga.com/trading-ideas/long-ideas/21/06/21737470/cathie-wood-buys-another-9-6m-in-uipath-raises-stake-in-automation-company-to-670m\">Benzinga</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QSI":"Quantum-Si Inc.","PATH":"UiPath"},"source_url":"https://www.benzinga.com/trading-ideas/long-ideas/21/06/21737470/cathie-wood-buys-another-9-6m-in-uipath-raises-stake-in-automation-company-to-670m","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110515408","content_text":"Cathie Wood-led Ark Investment Management on Friday snapped up 136,859 shares, estimated to be worth about $9.55 million, in UiPath Inc(NYSE:PATH).\nShares of the New York-based software automation company closed 1.04% higher at $69.77 on Friday.\nThe investment firm made the purchase via the ArkGenomic Revolution ETF(BATS:ARKG).\nArk owns PATH shares via all of its six active ETFs. On a consolidated basis, the Wood-led firm now holds over 10 million shares, worth around $670 million in UiPath.\nThe products of the Bucharest, Romania-based software companyare used by organizations to help efficiently automate their various business processes. PATH closed 5.34% higher on Wednesday, giving the company a market valuation of $35.8 billion.\nSome of the other key Ark Invest sells on Friday include Pluristem Therapeutics(NASDAQ:PSTI) and buys include Quantum-Si Inc(NASDAQ:QSI).","news_type":1,"symbols_score_info":{"PSTI":0.9,"QSI":0.9,"PATH":0.9}},"isVote":1,"tweetType":1,"viewCount":1165,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":384974986,"gmtCreate":1613611005045,"gmtModify":1634552959894,"author":{"id":"3572672756847501","authorId":"3572672756847501","name":"jamesrayan","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572672756847501","authorIdStr":"3572672756847501"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/384974986","repostId":"1109567373","repostType":4,"isVote":1,"tweetType":1,"viewCount":1296,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}